SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-323155
Filing Date
2018-11-09
Accepted
2018-11-09 08:01:44
Documents
62
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d623821d10q.htm 10-Q 751361
2 EX-10.1 d623821dex101.htm EX-10.1 768064
3 EX-31.1 d623821dex311.htm EX-31.1 6185
4 EX-31.2 d623821dex312.htm EX-31.2 6245
5 EX-32.1 d623821dex321.htm EX-32.1 4949
12 GRAPHIC g623821snap0001.jpg GRAPHIC 4666
13 GRAPHIC g623821snap0002.jpg GRAPHIC 3318
  Complete submission text file 0001193125-18-323155.txt   5144360

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ziop-20180930.xml EX-101.INS 659170
7 XBRL TAXONOMY EXTENSION SCHEMA ziop-20180930.xsd EX-101.SCH 48933
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20180930_cal.xml EX-101.CAL 43642
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20180930_def.xml EX-101.DEF 254728
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20180930_lab.xml EX-101.LAB 418185
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20180930_pre.xml EX-101.PRE 337008
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 181171423
SIC: 2834 Pharmaceutical Preparations